SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-106345
Filing Date
2024-10-04
Accepted
2024-10-04 17:27:55
Documents
1
Period of Report
2024-10-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2425653-13_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2425653-13_4seq1.xml 4 4263
  Complete submission text file 0001104659-24-106345.txt   5848
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Issuer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address LEAP THERAPEUTICS, INC. 47 THORNDIKE STREET, SUITE B1 CAMBRIDGE MA 02141
Business Address
Schilsky Richard (Reporting) CIK: 0001945662 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37990 | Film No.: 241355748